Pharmaceutical

Karnataka holds 64th Vision Group on Biotechnology meet...

Meeting discusses biotechnology strategy, AI integration, biomanufacturing and f...

Glenmark launches Methylene Blue Injection USP in US

Generic injectable approved as bioequivalent to ProvayBlue Injection 50 mg/10 mL

ALK’s EURneffy secures MHRA approval for anaphylaxis tr...

This approval is said to be the first in the UK for a needle-free adrenaline tre...

Alkermes’ alixorexton secures FDA and EC orphan designa...

The FDA granted the status to alixorexton for idiopathic hypersomnia while the E...

ILAMED expands international presence with centres in K...

Institute to launch Cairo centre in September 2026 as part of its overseas exp...

Simcere and Stanford partner to develop IPF therapies

Under the deal, Simcere will provide funding for exploratory research on a first...

FDA clears MSD’s Keytruda combo plus Welireg for ccRCC ...

This approval covers patients with ccRCC who are at intermediate-high or high ri...

Novartis India launches Pluvicto for PSMA-positive meta...

Radioligand therapy approved for eligible patients with PSMA-positive prostate ...

Ipca Laboratories and Bhami’s Research Laboratory signs...

Agreement enables development and commercialisation of monoclonal antibody prod...

Alembic receives USFDA final approval for Tretinoin Cre...

ANDA approved for Tretinoin Cream USP, 0.05%, referencing Retin-A Cream, 0.05% ...

Why ingredient transparency matters more than ever in c...

Dr Aishwarya Pandit highlights why ingredient transparency has become essential...

CDSCO’s cosmetic regulations: The rules exist. The enfo...

People have died in India’s aesthetic clinics. Not in rare surgical catastrophe...

China’s NMPA approves Akeso’s gumokimab for plaque psor...

The approval is based on data from one pivotal Phase III trial (AK111-301) and t...

FDA grants priority review for Roche’s Tecentriq combo ...

The application covers patients with stage III colon cancer characterised by def...

India Pharma 2035: The next global leadership story

Indore Pharma Summit 2026 | 8th May 2026 | Indore Marriott Hotel The post India...

Mr Murali Krishna Veeramallu, Head – Industrial Divisio...

Indore Pharma Summit 2026 | 8th May 2026 | Indore Marriott Hotel The post Mr Mu...